I

Intra-Cellular Therapies
D

ITCI

127.240
USD
0.73
(0.58%)
مغلق
حجم التداول
127,849
الربح لكل سهم
0
العائد الربحي
-
P/E
-146
حجم السوق
13,518,453,859
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    A
    ALKS
    0.140
    (0.47%)
    30.220 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    E
    ESPR
    0.05000
    (2.33%)
    2.20000 USD
    GSK
    GSK
    -0.340
    (-1.01%)
    33.440 USD
    LLY
    LLY
    11.37
    (1.53%)
    753.86 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    المزيد
الأخبار
المقالات

العنوان: Intra/Cellular Therapies

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.